Similar articles

• The clinical significance of molecular variation within the hepatitis B virus genome.

  Brown JL, Carman WF, Thomas HC. Brown JL, et al. Hepatology. 1992 Jan;15(1):144-8. doi: 10.1002/hep.1840150124. Hepatology. 1992. PMID: 1727790 Review. No abstract available.
• Hepatitis B virus genes and their expression in E. coli.

  Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K. Pasek M, et al. Nature. 1979 Dec 6;282(5739):575-9. doi: 10.1038/282575a0. Nature. 1979. PMID: 399329
• [The production and characteristics of transgenic mice expressing the surface protein gene of the human hepatitis B virus].

  Shvemberger IN, Ermilov AN, Kapitskaia MZ, Dvorianchikov GA, Medvedeva ND, Ginkul LB, Tomilin NV. Shvemberger IN, et al. Tsitologiia. 1990;32(3):252-5. Tsitologiia. 1990. PMID: 2171172 Russian.
• Production of 22 nm HBsAG particles by human lymphocytes infected with a recombinant vaccinia virus containing the coding sequence for hepatitis B virus surface antigen.

  Theilmann L, von Brunn A. Theilmann L, et al. Biochem Biophys Res Commun. 1991 Sep 30;179(3):1479-84. doi: 10.1016/0006-291x(91)91739-y. Biochem Biophys Res Commun. 1991. PMID: 1656954
• Mutations in the S-gene affecting the immunologic determinants of the envelope protein of hepatitis B virus.

  Lee HS, Ulrich PP, Vyas GN. Lee HS, et al. J Hepatol. 1991;13 Suppl 4:S97-101. doi: 10.1016/0168-8278(91)90035-a. J Hepatol. 1991. PMID: 1726591 Review. No abstract available.